American Portfolios Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

American Portfolios Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$29.2K	Buy	219 +1	+0.5%	+$152	﹤0.01%	2004
2022 Q2	$34K	Hold	218	–	–	﹤0.01%	1975
2022 Q1	$33.9K	Hold	218	–	–	﹤0.01%	2081
2021 Q4	$27.8K	Sell	218 -2	-0.9%	-$263	﹤0.01%	2179
2021 Q3	$28.7K	Buy	220 +2	+0.9%	+$302	﹤0.01%	2091
2021 Q2	$38.7K	Buy	218 +41	+23%	+$7.1K	﹤0.01%	1865
2021 Q1	$29.1K	Sell	177 -5,402	-97%	-$889K	﹤0.01%	1862
2020 Q4	$921K	Buy	5,579 +5,407	+3,144%	+$805K	0.05%	366
2020 Q3	$24.5K	Sell	172 -1,371	-89%	-$170K	﹤0.01%	1609
2020 Q2	$170K	Buy	1,543 +24	+2%	+$2.65K	0.01%	793
2020 Q1	$152K	Sell	1,519 -202	-12%	-$26.1K	0.01%	742
2019 Q4	$257K	Buy	1,721 +57	+3%	+$7.76K	0.02%	653
2019 Q3	$213K	Buy	1,664 +56	+3%	+$7.51K	0.02%	692
2019 Q2	$229K	Buy	1,608 +64	+4%	+$8.6K	0.02%	652
2019 Q1	$221K	Buy	1,544 +315	+26%	+$41.1K	0.02%	605
2018 Q4	$152K	Buy	1,229 +56	+5%	+$8.31K	0.02%	602
2018 Q3	$197K	Buy	1,173 +326	+38%	+$56.1K	0.02%	579
2018 Q2	$146K	Buy	847 +699	+472%	+$114K	0.02%	678
2018 Q1	$22.3K	Hold	148	–	–	﹤0.01%	1346
2017 Q4	$19.9K	Buy	+148	New	+$20.5K	﹤0.01%	1328

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

American Portfolios Advisors's JAZZ Position: Q3 2022 in Review

American Portfolios Advisors increased its Jazz Pharmaceuticals (JAZZ) stake by 0.46% in Q3 2022, buying an estimated $152 and bringing the position to 219 shares worth $29.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2004.

American Portfolios Advisors first reported a position in JAZZ in Q4 2017 and has held it in 20 quarters since. The position peaked at $921K in Q4 2020. 468 funds tracked by Wall St. Rank hold JAZZ as of Q3 2022.

American Portfolios Advisors held 219 shares of Jazz Pharmaceuticals worth $29.2K as of Q3 2022.
American Portfolios Advisors bought 1 Jazz Pharmaceuticals share in Q3 2022, an estimated $152.
Jazz Pharmaceuticals made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2004 holding.
American Portfolios Advisors first reported a position in Jazz Pharmaceuticals in Q4 2017 and has held it in 20 quarters since.
American Portfolios Advisors's Jazz Pharmaceuticals position peaked at $921K in Q4 2020.
468 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.